Repeated botulinum toxin type A injections for refractory overactive bladder: medium-term outcomes, safety profile, and discontinuation rates. (2012)
Attributed to:
MRC Centre for Transplantation
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.eururo.2011.12.011
PubMed Identifier: 22204745
Publication URI: http://europepmc.org/abstract/MED/22204745
Type: Journal Article/Review
Volume: 61
Parent Publication: European urology
Issue: 4
ISSN: 0302-2838